ANKRD30BL: A Potential Drug Target and Biomarker (G554226)

Target Name: ANKRD30BL

NCBI ID: G554226

ANKRD30BL: A Potential Drug Target and Biomarker

Ankyrin repeat domains (ANKRDs) are a class of gene repeats that have been identified in various organisms as having functional roles in regulation of gene expression. One of the ANKRD families, ANKRD30BL, has been identified in the human genome and is expressed in various tissues and cell types. The ANKRD30BL gene has a conserved region that includes an ANKRD domain and a non-coding region. The ANKRD domain is known for its ability to interact with various transcription factors and has been implicated in various cellular processes, including DNA replication, transcription, and gene expression.

The ANKRD30BL gene has been associated with various diseases, including cancer, neurodegenerative diseases, and developmental disorders. The ANKRD30BL gene has also been implicated in several diseases, including cardiovascular disease, metabolic diseases, and autoimmune diseases. These associations have led to the ANKRD30BL gene being a promising drug target and a biomarker for various diseases.

The ANKRD30BL gene has been shown to play a role in various cellular processes, including cell signaling, DNA replication, and gene expression. The ANKRD domain has been shown to interact with various transcription factors, including NF-kappa-B, AP-1, and STAT3. The non-coding region of the ANKRD30BL gene has been shown to include a regulatory element that can interact with the ANKRD domain.

The ANKRD30BL gene has also been shown to be involved in the development and progression of various diseases. For example, the ANKRD30BL gene has been shown to be involved in the development of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. The ANKRD30BL gene has also been shown to be involved in the development of cardiovascular disease, such as myocardial infarction and hypertension.

In addition to its association with diseases, the ANKRD30BL gene has also been shown to be a potential drug target. The ANKRD30BL gene has been shown to be involved in the regulation of various cellular processes, including cell signaling, DNA replication, and gene expression. The ANKRD domain has been shown to interact with various transcription factors, including NF-kappa-B, AP-1, and STAT3. The non-coding region of the ANKRD30BL gene has been shown to include a regulatory element that can interact with the ANKRD domain.

The ANKRD30BL gene has also been shown to be involved in the development and progression of various diseases. For example, the ANKRD30BL gene has been shown to be involved in the development of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. The ANKRD30BL gene has also been shown to be involved in the development of cardiovascular disease, such as myocardial infarction and hypertension.

In conclusion, ANKRD30BL is a gene that has been associated with various diseases, including cancer, neurodegenerative diseases, and developmental disorders. The ANKRD30BL gene has also been shown to play a role in various cellular processes, including cell signaling, DNA replication, and gene expression. The ANKRD domain has been shown to interact with various transcription factors, including NF-kappa-B, AP-1, and STAT3. The non-coding region of the ANKRD30BL gene has been shown to include a regulatory element that can interact with the ANKRD domain. Further research is needed to fully understand the role of the ANKRD30BL gene in diseases and to develop it as a potential drug target and biomarker.

Protein Name: Ankyrin Repeat Domain 30B Like

More Common Targets